| Socioeconomic status and environmental noise exposure in Montreal, Canada LM Dale, S Goudreau, S Perron, MS Ragettli, M Hatzopoulou, ... BMC public health 15, 1-8, 2015 | 102 | 2015 |
| The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities E Krebs, LM Dale HIV specialist 12 (1), 20, 2020 | 45 | 2020 |
| Sildenafil improves brain injury recovery following term neonatal hypoxia-ischemia in male rat pups A Yazdani, Z Khoja, A Johnstone, L Dale, E Rampakakis, P Wintermark Developmental neuroscience 38 (4), 251-263, 2016 | 26 | 2016 |
| Assessing the determinants of completing OAT induction and long-term retention: A population-based study in British Columbia, Canada M Kurz, JE Min, LM Dale, B Nosyk Journal of Substance Abuse Treatment 133, 108647, 2022 | 25 | 2022 |
| Estimates of opioid use disorder prevalence from a regression-based multi-sample stratified capture-recapture analysis JE Min, LA Pearce, F Homayra, LM Dale, JA Barocas, MA Irvine, ... Drug and Alcohol Dependence 217, 108337, 2020 | 23 | 2020 |
| Non-disclosure of drug use in outpatient health care settings: Findings from a prospective cohort study in Vancouver, Canada LA Pearce, F Homayra, LM Dale, S Moallef, B Barker, A Norton, ... International Journal of Drug Policy 84, 102873, 2020 | 15 | 2020 |
| Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study A Slaunwhite, JE Min, H Palis, K Urbanoski, B Pauly, B Barker, A Crabtree, ... BMJ 384, 2024 | 14 | 2024 |
| Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform S Moallef, L Dale, F Homayra, C Zonneveld, MJ Milloy, B Nosyk, ... Journal of Substance Abuse Treatment 139, 108784, 2022 | 7 | 2022 |
| Opioid agonist treatment uptake within provincial correctional facilities in British Columbia, Canada M Kurz, LM Dale, JE Min, N Hongdilokkul, L Greiner, M Olley, KE McLeod, ... Addiction 117 (5), 1353-1362, 2022 | 6 | 2022 |
| An exploration of transportation source contribution to noise levels near an airport LM Dale, M Debia, OC Mudaheranwa, C Plante, A Smargiassi Environment and Pollution 3 (1), 73, 2014 | 6 | 2014 |
| The effect of a methadone reformulation on opioid agonist treatment outcomes: A population-based study in British Columbia, Canada, 2013–14 E Krebs, N Hongdilokkul, LM Dale, JE Min, KT Schnepel, H Shigeoka, ... Journal of Substance Abuse Treatment 138, 108714, 2022 | 3 | 2022 |
| Opioid analgesic prescribing for opioid-naïve individuals prior to identification of opioid use disorder in British Columbia, Canada B Enns, E Krebs, T Thomson, LM Dale, JE Min, B Nosyk Addiction 116 (12), 3422-3432, 2021 | 2 | 2021 |
| Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014–20 B Nosyk, M Kurz, BC Guerra‐Alejos, M Piske, L Dale, JE Min Addiction 118 (7), 1376-1380, 2023 | 1 | 2023 |
| BC physicians reduce unnecessary antibiotic use-and costs DM Patrick, L Dale, M McCabe, B Zhao, M Chong, E Blondel-Hill, F Marra BRITISH COLUMBIA MEDICAL JOURNAL 58 (9), 501-+, 2016 | 1 | 2016 |
| Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study BB Pauly, M Kurz, LM Dale, C Macevicius, J Kalicum, DG Pérez, J McCall, ... Journal of Substance Use and Addiction Treatment 161, 209341, 2024 | | 2024 |
| Comparative effectiveness of urine drug screening strategies alongside opioid agonist treatment in British Columbia, Canada: a population-based observational study protocol BC Guerra-Alejos, M Kurz, JE Min, LM Dale, M Piske, P Bach, J Bruneau, ... BMJ open 13 (5), e068729, 2023 | | 2023 |
| Commentary on Krawczyk et al.(2020): Reinforcing the case for evidence‐based treatment of opioid use disorder. LM Dale, B Nosyk Addiction 115 (9), 2020 | | 2020 |
